Press Release: IriSys : IRISYS Awarded $850,000 NIH Contract for the Formulation of Drinabant, a Drug in Development for Treatment of Acute Cannabinoid Overdose

IRISYS is a California-based CDMO that provides services such as clinical development, product formulation and analytical support for the pharmaceutical industry.